Leadership Team

Roy Jensen, MD Director, KU Cancer Center CEO, Midwest Cancer Alliance	Terance T. Tsue, MD, FACS Vice President and Physician-in-Chief, The University of Kansas Cancer Center
Shrikant Anant, PhD Associate Director, Basic Science	Joaquina Baranda, MD Director, Early-Phase Program, Clinical Research
Christie Befort, PhD Associate Director, Cancer Prevention and Control Co-leader, Cancer Control & Population Health	Teresa Christenson Associate Director Administration
Dan Dixon, PhD Co-Leader, Cancer Prevention and Survivorship	Gary Doolittle, MD Medical Director, Midwest Cancer Alliance
Edward Ellerbeck, MD, MPH Co-Leader, Cancer Control and Population Health	Carol Fabian, MD Associate Director, Clinical Research
Alan Gamis, MD Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Program	Andrew Godwin, PhD Deputy Director, The University of Kansas Cancer Center Director, Biospecimen Repository
Jennifer Klemp, PhD Co-leader, Cancer Prevention and Survivorship Program	Linheng Li, PhD Co-leader, Cancer Biology
Tara Lin, MD Medical Director, Clinical Trials Office	Sally Maliski, PhD Associate Director, Equity
Matthew Mayo, PhD Associate Director, Shared Resources	Kristi Neufeld, PhD Co-Leader, Cancer Biology
Jeffrey Reene, MBA Chief Operating Officer	Weijing Sun, MD Division Director, Medical Oncology; Associate Director for Clinical Research
John Taylor, MD, MS Co-leader, Drug Discovery, Delivery and Experimental Therapeutics	Scott Weir, PharmD, PhD Associate Director, Translational Research; Director, Institute for Advancing Medical Innovation
Danny Welch, PhD Associate Director, Education